Artículos de revistas
Prevalence Of Pulmonary Hypertension In Systemic Sclerosis [avaliação Da Prevalência De Hipertensão Pulmonar Na Esclerose Sistêmica]
Registro en:
Revista Brasileira De Reumatologia. , v. 44, n. 1, p. 31 - 39, 2004.
4825004
2-s2.0-55449120724
Autor
de Azevedo A.B.C.
Sampaio-Barros P.D.
Torres R.M.
Moreira C.
Institución
Resumen
Objective: To assess the prevalence of pulmonary arterial hypertension (PAH) in patients with diagnosis of systemic sclerosis (SSc) evaluated at a university tertiary service. Methods: Fifty-seven SSc patients attending the Rheumatology outpatient clinic of HC-UFMG were studied by clinical assessment addressed to cardiopulmonary system, pulmonary function tests and Doppler echocardiography (ECO). The following criteria were considered for the diagnosis of PAH: pulmonary arterial systolic pressure (PASP) ≥ 40mmHg and/or the presence of direct or indirect signs of PAH found during the ECO. Results: Sixteen patients (28%) were found to have the diagnosis of PAH at ECO, 13 with PASP ≥ 40mmHg and 3 with direct and indirect signs of PAH; 8 patients had isolated PAH and 8, PAH secondary to pulmonary fibrosis. Nine patients had suggestive signs of cor pulmonale at ECO; 6 of these patients presented PASP ≥ 40mmHg and 3 PASP between 35 and 40mmHg; 1 of them was not symptomatic and 8 had clinical exam suggestive of PAH. Regarding the clinical and laboratory variables studied, it was observed statistical association between PAH and elevated erythrocyte sedimentation rate (ESR) (p = 0,004). Conclusions: There was a prevalence of PAH in SSc similar to that observed in the literature, in spite of limitations in this comparison. The assessment of PAH by ECO is accessible and practical; however, it is necessary to review the cut off of the PASP levels considered for the diagnosis of PAH in SSc, especially when considering an early diagnosis. 44 1 31 39 Marques Neto, J.F., Sampaio-Barros, P.D., Esclerose Sistêmica (2001) Reumatologia Diagnóstico e Tratamento, pp. 465-488. , Em Moreira C, Carvalho MAP (Editores): 2a edição, MEDSI, Belo Horizonte Wigley, F.M., Clinical Features of Systemic Sclerosis (1998) Rheumatology, 7 (9), pp. 1-14. , Em Klippel JH, Dieppe PA (Editores): 2a edição, Mosby, London Denton, C.P., Black, C.M., Pulmonary Vascular Involvement in Systemic Sclerosis (2004) Systemic sclerosis, pp. 184-194. , Em Clements PJ, Furst DE (Editores): 2a edição, Lippincott Williams & Wilkins, Filadélfia Denton, C.P., Black, C.M., Pulmonary hypertension in systemic sclerosis (2003) Rheum Dis Clin North Am, 29, pp. 371-390 Denton, C.P., Cailes, J.B., Phillipis, G.D., Wells, A.U., Black, C.M., du Bois, R.M., Comparison of Doppler echocardiography and right heart catheterization in systemic sclerosis (1997) Br J Rheumatol, 36, pp. 239-243 Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis Rheum, 23, pp. 581-590. , Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Leroy, E.C., Black, C., Fleischmajer, R., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis (1988) J Rheumatol, 15, pp. 202-205 Otto, C.M., (2000) Textbook of Clinical Echocardiography, , 2aedição, W. B. Saunders, Filadélfia (1996) J Bras Pneumol, 22, pp. 105-164. , I Consenso Brasileiro sobre Espirometria 1996 Steen, V., Predictors of end stage lung disease in systemic sclerosis (2003) Ann Rheum Dis, 62, pp. 97-99 Magliano, M., Isenberg, D.A., Hillson, J., Pulmonary hypertension in autoimmune rheumatic diseases. Where are we now? (2002) Arthritis Rheum, 46, pp. 1997-2009 Vancheeswaran, R., Magoulas, T., Efrat, G., Circulating endothelin-1 levels in systemic sclerosis subsets - a marker of fibrosis or vascular dysfunction? (1994) J Rheumatol, 21, pp. 1838-1844 Mitri, G.M., Lucas, M., Fertig, N., Steen, V.D., Medsger Jr., T.A., A comparison between anti-Th/To and anticentromere antibodypositive systemic sclerosis patients with limited cutaneous involvement (2003) Arthritis Rheum, 48, pp. 203-209 Sacks, D.G., Okano, Y., Steen, V.D., Curtiss, E., Shapiro, L.S., Medsger Jr., T.A., Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: Association with serum anti-U3RNP antibody (1996) J Rheumatol, 23, pp. 639-642 Steen, V., Mesdger Jr., T.A., Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement (2003) Arthritis Rheum, 48, pp. 516-522 Yamane, K., Ihn, H., Asano, Y., Clinical and laboratory features of scleroderma patients with pulmonary hypertension (2000) Rheumatology, 39, pp. 1269-1271 Steen, V., Conte, C., Owens, G., Mesdger Jr., T.A., Severe restrictive lung disease in systemic sclerosis (1994) Arthritis Rheum, 37, pp. 1283-1289 Morgan, C., Knight, C., Lunt, M., Black, C.M., Silman, A.J., Predictors of end stage lung disease in a cohort of patients with scleroderma (2003) Ann Rheum Dis, 62, pp. 146-150 Sackner, M.A., Heinz, E.R., Steinberg, A.J., The heart in scleroderma (1966) Am J Cardiol, 17, pp. 542-559 Stupi, A.M., Steen, V., Owens, G.R., Barnes, E.L., Rodnan, G.P., Mesdger Jr., T.A., Pulmonary hypertension in the CREST Syndrome variant of systemic sclerosis (1986) Arthritis Rheum, 29, pp. 515-524 Sampaio-Barros, P.D., Leme, C.A., Marques Neto, J.F., Valor do ecocardiograma com doppler na esclerose sistêmica (1995) Rev Bras Reumatol, 35, pp. 327-331 Koh, E.T., Lee, P., Gladman, D.D., Abu-Shakra, M., Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients (1996) Br J Rheumatol, 35, pp. 989-993 Battle, R.W., Davitt, M.A., Cooper, S.M., Prevalence of pulmonary hypertension in limited and diffuse scleroderma (1996) Chest, 110, pp. 1515-1519 Murata, I., Takenaka, K., Yoshinoya, S., Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. a Doppler echocardiographic study of 135 Japanese patients (1997) Chest, 111, pp. 36-43 MacGregor, A.J., Canavan, R., Knight, C., Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival (2001) Rheumatology, 40, pp. 453-459 Mukerjee, D., St George, D., Coleiro, B., Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach (2003) Ann Rheum Dis, 62, pp. 1088-1093 Rich, S., (1998) World Symposium on Primary Pulmonary Hypertension, , www.who.int/ncd/cvd/pph.html, Evian, France Merkel, P.A., Clements, P.J., Reveille, J.D., Suarez-Almazor, M.E., Valentini, G., Furst, D.E., Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6 (2003) J Rheumatol, 30, pp. 1630-1647